The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma

The launch of novel chemotherapeutic agents—in particular, proteasome inhibitors and immunomodulatory drugs—dramatically changed multiple myeloma (MM) therapy, improving the response rate and prolonging progression-free survival. However, none of the anti-MM drugs are deprived of side effects. Perip...

Descripción completa

Detalles Bibliográficos
Autores principales: Łuczkowska, Karolina, Rutka, Magdalena, Rogińska, Dorota, Paczkowska, Edyta, Baumert, Bartłomiej, Milczarek, Sławomir, Górska, Martyna, Kulig, Piotr, Osękowska, Bogumiła, Janowski, Michał, Safranow, Krzysztof, Sommerfeld, Krzysztof, Borowiecka, Ewa, Zawodny, Piotr, Koclęga, Anna, Helbig, Grzegorz, Machaliński, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509696/
https://www.ncbi.nlm.nih.gov/pubmed/34640602
http://dx.doi.org/10.3390/jcm10194584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509696/
https://www.ncbi.nlm.nih.gov/pubmed/34640602
http://dx.doi.org/10.3390/jcm10194584

Ejemplares similares